Thanks for putting all of these in one place; given the 'compelling' nature of the observations I'd say at least 6 have responded (3 out of the first six; and since they have stated they know that can conclude after two more, at least 3 in Stage 2 have responded IMHO) out of the total of 18 so far, probably more IMHO. All using the sh!tty old RC110 formulation! We kind of know from the COH paper that reformulating helps it to work even better - I'm sure RC220 takes advantage of this technique/know-how (and maybe necessitates the announced licensing).
3 out of the first 6. Announced to market.
At least 1 of the next 9 to get us to 15 patients. We know this because they continued after the first 9 in this stage.
At least 6 out the first 18 patients, which includes 3 of the 10 patients in Stage 2 to date. Probably more. We know it's at least three in this second stage IMHO because they have said they know they can conclude after treating 2 more.
IMHO, 7 is included in what they define as "several" out of the 18 so far treated.
Ann: Zantrene AML trial in Israel advances to Phase 2, page-104
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.57 | $387.6K | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 807 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 2376 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |